Publicaciones en colaboración con investigadores/as de Charité (24)

2024

  1. Applicability of heart failure clinical practice guidelines in low- and middle-income countries

    European Journal of Heart Failure

  2. Cardiac wasting and cancer

    European Heart Journal

  3. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 18-33

  4. Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2

    Journal of the American College of Cardiology

  5. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials

    European Journal of Heart Failure, Vol. 26, Núm. 7, pp. 1608-1615

2021

  1. Advanced cancer is also a heart failure syndrome: a hypothesis

    European Journal of Heart Failure, Vol. 23, Núm. 1, pp. 140-144

  2. Advanced cancer is also a heart failure syndrome: a hypothesis

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 3, pp. 533-537

  3. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe

    American Journal of Medicine, Vol. 134, Núm. 4, pp. 482-489

  4. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

  5. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Heart Journal, Vol. 42, Núm. 13, pp. 1254-1269

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

    European Heart Journal, Vol. 41, Núm. 1, pp. 111-188

  3. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    The Lancet, Vol. 396, Núm. 10266, pp. 1895-1904

  4. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 22, Núm. 2, pp. 181-195

  5. Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool

    Atherosclerosis Supplements, Vol. 42, pp. e65-e71

  6. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

2018

  1. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

    European Heart Journal, Vol. 39, Núm. 14, pp. 1131-1143

  2. New prospects for PCSK9 inhibition?

    European heart journal

  3. Wytyczne ESC/EACTS dotyczace leczenia zastawkowych wad serca w 2017: Roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) i Europejskiego Towarzystwa Kardio- i Torakochirurgów (EACTS) do spraw leczenia zastawkowych wad serca

    Kardiologia Polska, Vol. 76, Núm. 1, pp. 1-62